Project Grant HT94252510420
Award Date
9/1/25
Completion Date
8/31/27
Dollars Obligated
$750K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Austin, TX 78712, USA
Similar Awards
The University of Texas at Austin has been awarded a $649,769.00 Cooperative Agreement by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This award will support a multi-modal research approach to reduce vascularized composite allograft (VCA) immunogenicity and improve functional outcomes. The research will be conducted at the University of Texas at Austin campus located in Austin, TX 78712. As the prime awardee, the University of Texas at...
The University of Texas Health Science Center at Houston was awarded a $1,498,514 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program. The grant will fund research from September 2022 through September 2026 to improve functional performance in transfemoral amputees through somatosensory augmentation. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The University of Texas at Austin was awarded a $1,499,767 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to investigate the impact of personalized robotic leg prostheses for individuals with transfemoral amputations of varying mobility levels. The research will be conducted from September 2022 through September 2026. A subaward of $150,000 was provided to the Georgia Tech Research Corporation to support...
The University of Texas Southwestern Medical Center was awarded a $2,641,871 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2023 through April 30, 2027 to comprehensively upregulate and stabilize frataxin mRNA using antisense oligonucleotides. The goal of this research is to transform health care for service members and the public by investigating medical solutions for the...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $909,532.00 to The University of Texas Southwestern Medical Center to conduct research on validating a nonopioid analgesic pathway in human sensory ganglia and spinal cord. The award has a performance period from September 15, 2024 to September 14, 2025. The research aims to explore innovative, non-opioid based approaches to pain management, which is a...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,560,000.00 to the University of Texas Health Science Center at Houston (UTHealth) to develop drug conjugates of modified LGR4/5/6 ligands for cancer treatment. The funding supports UTHealth's advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award period runs from August 1, 2024...
The University of Texas at Austin received a $396,605 Project Grant award from the Department of Defense under the Basic, Applied, and Advanced Research in Science and Engineering program (CFDA 12.630). The award, effective September 1, 2024 through August 31, 2025, will fund the procurement of equipment to support research that enhances the resilience and cyber-physical security of military microgrids. The project aims to deliver technological innovations that strengthen the security and...
This $1,559,880 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support the "PEGASUS: PREGNANCY COMPLICATIONS IN AYA CANCER SURVIVORS" research project at the University of Texas Health Science Center at Houston (UTHealth). The award, effective April 1, 2025 through March 31, 2029, will fund advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,336 project grant to The Trustees of the Stevens Institute of Technology on March 1, 2024. The grant will support research and development of "BIOACTIVE NERVE GRAFTS FOR PERIPHERAL NERVE REGENERATION" over a 4-year period ending February 29, 2028. As a sub-award under this project, the University of Connecticut Health Center (UCHC) will also conduct research related to this...